Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Cash & Current Investments (2010 - 2026)

Vericel (VCEL) posted Cash & Current Investments of $162.5 million for Q2 2026, up 11.8% sequentially from $145.3 million in Q1 2026, and up 39.03% YoY from $116.9 million in Q2 2025.

Analysis

Vericel (VCEL) Cash & Current Investments (2010 - 2026) Analysis & Trends

Vericel has reported Cash & Current Investments for 15 years, with the latest figure at $162.5 million in Q2 2026.

  • Quarterly Cash & Current Investments rose 39.03% year-over-year to $162.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $162.5 million (up 39.03% YoY) and the FY2025 annual result came in at $137.5 million, up 18.32% from the prior year.
  • Cash & Current Investments rose to $162.5 million in Q2 2026 per VCEL's latest filing, from $145.3 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $162.5 million in Q2 2026 and troughed at $97.8 million in Q2 2023.
  • A 5-year average of $117.0 million and a median of $111.9 million in 2022 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2023 and 2026: Cash & Current Investments declined 8.35% in 2023, then soared 39.03% in 2026.
  • Over 5 years, Cash & Current Investments stood at $119.5 million in 2022, then decreased by 8.35% to $109.6 million in 2023, then climbed by 6.08% to $116.2 million in 2024, then climbed by 18.32% to $137.5 million in 2025, then increased by 18.18% to $162.5 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $162.5 million, $145.3 million, and $137.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 162.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 162.50 Mn
Mar 31, 2026 145.35 Mn
Dec 31, 2025 137.50 Mn
Sep 30, 2025 135.38 Mn
Jun 30, 2025 116.88 Mn
Mar 31, 2025 112.90 Mn
Dec 31, 2024 116.21 Mn
Sep 30, 2024 101.73 Mn
Jun 30, 2024 102.51 Mn
Mar 31, 2024 110.65 Mn
Dec 31, 2023 109.56 Mn
Sep 30, 2023 105.34 Mn
Jun 30, 2023 97.83 Mn
Mar 31, 2023 119.28 Mn
Dec 31, 2022 119.54 Mn
Sep 30, 2022 110.94 Mn
Jun 30, 2022 100.69 Mn
Mar 31, 2022 100.55 Mn
Dec 31, 2021 103.40 Mn
Sep 30, 2021 98.29 Mn